2027 Outlook for the Medical Liquid Silicone Industry: Precision Composite Molding Drives Innovation and Upgrading of Medical Devices

The global medical device industry is evolving toward miniaturization, integration, heightened compliance, and enhanced reliability. Medical liquid silicone rubber (LSR), owing to its exceptional biocompatibility, resistance to repeated sterilization, and precision molding capabilities, has become a core elastic material for minimally invasive diagnostics and therapies, wearable monitoring devices, home-based rehabilitation solutions, and sensor-based medical devices. LSR is progressively replacing solid silicone, TPE, and conventional rubber, with market demand continuing to rise steadily.

The annual growth rate of the medical-grade LSR market has remained above 7.5%, with multi-material composite precision silicone components exhibiting the fastest growth. The industry has moved beyond the era of low-cost, volume-based contract manufacturing, and its competitive focus has shifted toward three key barriers to entry: manufacturing capabilities, compliance frameworks, and mass-production stability.

I.Three Key Trends in Medical LSR

1.Equipment integration and integrated molding of multiple materials have become essential requirements.

The new generation of medical devices is pursuing compact designs. The traditional modular assembly approach—combining plastic and silicone—characterized by numerous seams, challenges in sterilization, wide assembly tolerances, and relatively high failure rates, is increasingly failing to meet the stringent requirements of high-end medical device design.

Currently, mainstream new medical products widely adopt composite structures consisting of LSR + plastic, LSR + metal, or LSR-clad FPC flexible circuit boards. By leveraging dual-color integrated molding, insert encapsulation, and FPC cladding processes, a single product can simultaneously achieve sealing, waterproofing, insulation, cushioning, and sensing protection. This multi-material integrated molding approach has become a standard solution for high-end medical components.

2.As global compliance standards tighten, low-end production capacity is being rapidly phased out.

Standards such as the EU MDR, ISO 13485, ISO 10993 (biocompatibility), and German LFGB continue to tighten, imposing stringent requirements on raw material traceability, absence of leaching, sterilization resistance, and batch consistency.

Many factories can only produce monochromatic silicone products and lack in-house mold capabilities; consequently, their entire silicone coating process is outsourced. Secondary manual coating often leads to layering and silicone overflow, results in fragmented and incomplete documentation, and ultimately prevents these factories from passing audits by medical clients. As a result, high-end medical orders are increasingly being concentrated in factories that possess one-stop compliant production capabilities.

3.Repetitive sterilization scenarios: consolidating LSR's irreplaceable advantages

Medical devices often require resistance to sterilization methods such as high-temperature steam, ethylene oxide, and gamma radiation. After repeated sterilization cycles, conventional elastic materials are prone to discoloration, cracking, and the leaching of substances exceeding permissible limits.

High-purity medical liquid silicone exhibits stable performance and excellent biocompatibility, making it suitable for prolonged human contact and repeated sterilization. It is widely used in critical medical components such as valve discs, seals, catheter fittings, and sensor encapsulation materials.

II. Industry Pain Points: There is no shortage of conventional silicone production capacity, but there is a lack of stable, large-scale composite molding production capabilities.

Most traditional silicone manufacturers commonly face these shortcomings when producing medical composite components.

Limited process capability: capable of producing only monochromatic silicone rubber, but unable to perform precision dual-color integrated molding; relies on manual secondary encapsulation, resulting in low yield rates and a high susceptibility to layering and silicone overflow.

Supply chain fragmentation: plastic, hardware, and FPC components are all outsourced for manufacturing; however, collaboration among multiple suppliers has led to loss of precision control, fluctuating lead times, and gaps in compliance documentation.

Insufficient early-stage risk assessment: lack of DFM review and mold flow simulation led to frequent batch quality issues—such as deformation, delamination, and dimensional out-of-tolerance—during mass production.

Incomplete service chain: limited to pure contract manufacturing, lacking the capability to provide integrated one-stop support—including mold development, sample validation, and comprehensive compliance documentation—in a synchronized manner.

III. Our Advantages: One-stop LSR precision composite molding solutions tailored to meet the mass production requirements of high-end medical applications.

Addressing the pain points in medical product development and mass production, we specialize in medical-grade liquid silicone precision composite molding, offering end-to-end ODM services—from mold design → sample validation → small-batch trial production → large-scale delivery—to meet the supply chain audit standards of domestic and international medical brands.

The factory is equipped with over 70 molding machines, including four-station dual-color molding machines, liquid silicone molding machines, and plastic molding machines. All production processes are completed in-house without external outsourcing, enabling the independent execution of plastic injection molding, LSR dual-color integrated molding, silicone encapsulation of hardware components, and FPC flexible circuit board encapsulation—thereby mitigating quality risks associated with the supply chain from the source.

Prior to project launch, we conducted DFM manufacturability assessments combined with mold flow simulations to proactively identify risks such as resin overflow, stress-induced deformation, and FPC damage. By replacing conventional secondary encapsulation with in-mold integration molding, we addressed challenges including resin delamination and material degradation following repeated sterilization cycles, thereby ensuring high yield rates in mass production.

Our raw materials are of medical-grade quality, with full traceability throughout the supply chain. Supported by a comprehensive quality control system, we provide biocompatibility testing, safety assessments, and material traceability documentation, ensuring compliance with global regulatory standards including ISO 13485, MDR, LFGB, and RoHS.

IV.Industry Outlook: Composite LSR components will become the primary growth driver

Over the next 2–3 years (up to 2027 and beyond), medical devices will continue to evolve toward miniaturization and intelligence. Demand for monochromatic silicone components is expected to stabilize, while multi-material composite LSR precision components are poised to experience rapid growth.

The supply chain landscape is undergoing a fundamental transformation: contract manufacturing capacities that rely solely on low pricing and limited production processes will gradually be phased out. Suppliers equipped with proprietary molds, integrated multi-material molding capabilities, full-process compliance, and consistent delivery capabilities will emerge as long-term strategic partners for global healthcare brands.

In the second half of the medical silicone market, the key differentiator is no longer the lowest unit price, but rather lower quality and risk, more comprehensive compliance documentation, faster time-to-market for new products, and more consistent product quality and quantity.

Conclusion

Amid evolving global medical regulatory standards and product portfolio innovations, LSR precision composite molding has become an indispensable core process for high-end medical devices. We continue to deepen our expertise in customized medical liquid silicone solutions, leveraging our mature multi-material composite molding technologies and end-to-end delivery capabilities to provide domestic and international medical clients with high-precision, high-safety, and high-reliability LSR solutions—thereby accelerating the transition of new products from design drawings to mass production.

Are you looking to undertake medical silicone projects that require DFM evaluation, mold development, sample production, or mass production coordination? We invite you to contact us for further discussion.